healthcare-costs
5 stories related to this topic, newest first.
Unknown authorUnknown author / Wikimedia (CC0)Department of Justice Charges New York-Presbyterian Hospital with Antitrust Violations
The Department of Justice has charged New York-Presbyterian Hospital with antitrust violations related to its contracts with insurance companies. A congressional committee is set to hold a hearing on hospital practices next week. The case highlights issues with hospital competiti…
thehindu.comNew Oral GLP-1 Drugs Offer Maintenance Option for Weight Loss After Injections
Eli Lilly and Novo Nordisk have introduced oral versions of their GLP-1 receptor agonist drugs for weight management. These pills provide an alternative to weekly injections, with clinical data showing they help maintain weight loss. Side effects and costs remain similar to the i…
Substrate placeholder — needs review · Wikimedia Commons (CC BY-SA 3.0)Research Estimates Long Covid to Cost OECD Economies Up to $135 Billion Annually Over Next Decade
New research projects that long Covid could impose annual economic costs of up to $135 billion on OECD countries over the next 10 years. The analysis highlights ongoing effects from the Covid-19 pandemic despite its apparent end. Affected economies include those in the Organisati…
RMHare / Wikimedia (CC0)Health Insurers and Hospitals Recognize AI Scribes Increase Healthcare Costs Without Consensus on Solutions
Health insurers and hospitals have acknowledged in private discussions that AI scribes are contributing to higher healthcare costs. The technology, used to automate clinical documentation, has led to increased billing and administrative expenses. While both parties agree on the i…
Hunted230 / Wikimedia (CC BY-SA 3.0)First-Time Users of Weight-Loss Medicines Seek Lower Costs and Greater Convenience from Novo Nordisk and Eli Lilly Pills
Seven doctors specializing in obesity report that Americans beginning weight-loss treatments prioritize reduced costs and improved convenience. These patients are evaluating oral medications from Novo Nordisk and Eli Lilly. The preferences reflect ongoing discussions in the obesi…